Binding sites of anticancer drugs on human serum albumin (HSA): a review

P Molaei, H Mahaki, H Manoochehri… - Protein and peptide …, 2022 - ingentaconnect.com
Background: To recognize the action of pharmacologically approved anticancer drugs in
biological systems, information regarding its pharmacokinetics, such as its transport within …

[HTML][HTML] Investigating the role of peptides in effective therapies against cancer

R Naeimi, A Bahmani, S Afshar - Cancer Cell International, 2022 - Springer
Early diagnosis and effective treatment of cancer are challenging. To diagnose and treat
cancer effectively and to overcome these challenges, fundamental innovations in traditional …

[HTML][HTML] CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway

Y Wang, L Yin, X Sun - Journal of Experimental & Clinical Cancer …, 2020 - Springer
Background Endometrial cancer (EC) is a common gynecologic malignancy worldwide. This
study investigated the regulatory effects of circular RNA (circRNA) hsa_circ_0002577 on the …

Identification of key genes in colorectal cancer diagnosis by weighted gene co-expression network analysis

M Mortezapour, L Tapak, F Bahreini, R Najafi… - Computers in Biology …, 2023 - Elsevier
Background The purpose of this study was using bioinformatics tools to identify biomarkers
and molecular factors involved in the diagnosis of colorectal cancer, which are effective for …

[HTML][HTML] A systems biology approach to identify novel biomarkers in progression from Crohn's disease to colorectal cancer

N Shokrollah, P Samadi, A Jalali… - Asian Pacific Journal …, 2023 - ncbi.nlm.nih.gov
Objective: This study aimed to find the key genes and miRNAs as potential biomarkers
related to the progression of colorectal cancer (CRC) from Crohn's disease (CD) …

[HTML][HTML] A network-based pharmacological investigation to identify the mechanistic regulatory pathway of andrographolide against colorectal cancer

B Janani, M Vijayakumar, K Priya, JH Kim… - Frontiers in …, 2022 - frontiersin.org
Traditional cancer treatments have posed numerous obstacles, including toxicity, multiple
drug resistance, and financial cost. On the contrary, bioactive phytochemicals used in …

Design and synthesis of novel pyrazolopyrimidine candidates as promising EGFR-T790M inhibitors and apoptosis inducers

AA Gaber, M Sharaky, AA Elmaaty… - Future Medicinal …, 2023 - Taylor & Francis
Aim: Our objective was to design and synthesize a new range of pyrazolopyrimidines while
maintaining the key pharmacophoric features of EGFR tyrosine kinase inhibitors. Materials & …

Investigating the effect of radiosensitizer for Ursolic Acid and Kamolonol Acetate ‌ on HCT-116 cell line

MH Abdali, S Afshar, AS Pashaki, D Dastan… - Bioorganic & Medicinal …, 2020 - Elsevier
Purpose The aim of this study was evaluating the cytotoxic and radiosensitizing effects of
Ursolic Acid (UA) and Kamolonol Acetate (KA) on HCT116 cell line and finally investigating …

[HTML][HTML] Introducing novel key genes and transcription factors associated with rectal cancer response to chemoradiation through co-expression network analysis

S Afshar, T Leili, P Amini, I Dinu - Heliyon, 2023 - cell.com
Preoperative radiochemotherapy is a promising therapeutic method for locally advanced
rectal cancer patients. However, the response of colorectal cancer (CRC) patients to …

N6-methyladenosine methylation analysis of long noncoding RNAs and mRNAs in 5-FU-resistant colon cancer cells

J Lai, Z Zhou, K Hu, HL Yu, X Su, X Niu, H Li, S Mao - Epigenetics, 2024 - Taylor & Francis
ABSTRACT N6 methyladenosine (m6A), methylation at the sixth N atom of adenosine, is the
most common and abundant modification in mammalian mRNAs and non-coding RNAs …